Quick Links

Publications:

Potential role of renin-angiotensin system blockade for preventing myocardial ischemia/reperfusion injury and remodeling after m

Authors: Wangde Dai|||Robert A Kloner

Journal: Postgraduate medicine

Publication Type: Journal Article

Date: 2011

DOI: 10.3810/pgm.2011.03.2263

ID: 21474893

Affiliations:

Affiliations

    The Heart Institute of Good Samaritan Hospital, Division of Cardiovascular Medicine of the Keck School of Medicine, University of Southern California, Los Angeles, CA 90017, USA. wangdedai@yahoo.com|||

Abstract

Experimental and clinical studies have demonstrated that myocardial ischemia induces activation of various components of the renin-angiotensin system (RAS), including angiotensinogen, renin, angiotensin-converting enzyme (ACE), angiotensins, and angiotensin receptors, in the acute phase of myocardial infarction and the postinfarction remodeling process. Pharmacological inhibition of the RAS by administration of renin inhibitors, ACE inhibitors, and angiotensin receptor blockers has shown beneficial effects on the pathological processes of myocardial infarction in both experimental animal studies and clinical trials. However, the potential mechanisms responsible for the cardioprotection of RAS inhibition remain unclear. In this review, we discuss roles of RAS blocking in the prevention of myocardial ischemia/reperfusion injury and postinfarction remodeling.


Chemical List

    Angiotensin-Converting Enzyme Inhibitors|||Renin